From the Research
Patient Risk Stratification
- The Rockall score is a widely used risk stratification system for patients with upper gastrointestinal bleeding (UGIB) 1, 2, 3, 4, 5.
- A pre-endoscopy Rockall score of 1 indicates a low to moderate risk of rebleeding and mortality 2, 4.
Prostaglandins vs Proton Pump Inhibitors (PPI)
- There is no direct evidence to suggest that patients with a pre-endoscopy Rockall score of 1 require prostaglandins over PPIs 1, 2, 3, 4, 5.
- PPIs are commonly used to reduce the risk of rebleeding in patients with UGIB, and their use is supported by clinical guidelines 5.
Risk Factors for Rebleeding
- A high Rockall score (≥ 6) has been associated with an increased risk of rebleeding in patients with UGIB 3, 4, 5.
- Other risk factors for rebleeding include active bleeding, visible hemoclips, and anatomical variants, although the evidence is not consistent across all studies 3.
- The use of a standardized embolization procedure and the number of endoscopies prior to embolization may also impact the risk of rebleeding 3.
Clinical Decision-Making
- Clinical decision-making should be based on a comprehensive assessment of the patient's risk factors, including the Rockall score, and the presence of other comorbidities or complications 1, 2, 3, 4, 5.
- The choice of treatment, including the use of prostaglandins or PPIs, should be individualized based on the patient's specific needs and risk profile 1, 2, 3, 4, 5.